Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
704 (USA) · Dr. Tanaka
consented 2012-09-19
AEs
3
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Mild INFLUENZA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-09-27 (study day 9.0); relationship: NONE
mild
assessed
Mild INFLUENZA — outcome: RECOVERED/RESOLVED; onset 2012-09-27 (study day 9.0); relationship: NONE
mild
assessed
Mild OEDEMA PERIPHERAL — outcome: RECOVERED/RESOLVED; onset 2013-02-04 (study day 139.0); relationship: NONE
Data queries
No data queries.